FR21C1009I1 - Composition solide pour administration orale de colorants et ses applications en diagnostic - Google Patents

Composition solide pour administration orale de colorants et ses applications en diagnostic

Info

Publication number
FR21C1009I1
FR21C1009I1 FR21C1009C FR21C1009C FR21C1009I1 FR 21C1009 I1 FR21C1009 I1 FR 21C1009I1 FR 21C1009 C FR21C1009 C FR 21C1009C FR 21C1009 C FR21C1009 C FR 21C1009C FR 21C1009 I1 FR21C1009 I1 FR 21C1009I1
Authority
FR
France
Prior art keywords
dyes
oral administration
solid composition
diagnostic applications
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR21C1009C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosmo Technologies Ltd
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of FR21C1009I1 publication Critical patent/FR21C1009I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR21C1009C 2010-03-04 2021-02-18 Composition solide pour administration orale de colorants et ses applications en diagnostic Active FR21C1009I1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A000345A IT1398643B1 (it) 2010-03-04 2010-03-04 Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
US32755710P 2010-04-23 2010-04-23
PCT/IB2011/050881 WO2011107945A1 (en) 2010-03-04 2011-03-02 Solid composition for the oral administration of dyes and diagnostic use thereof

Publications (1)

Publication Number Publication Date
FR21C1009I1 true FR21C1009I1 (fr) 2021-05-07

Family

ID=42647312

Family Applications (1)

Application Number Title Priority Date Filing Date
FR21C1009C Active FR21C1009I1 (fr) 2010-03-04 2021-02-18 Composition solide pour administration orale de colorants et ses applications en diagnostic

Country Status (26)

Country Link
US (6) US8545811B2 (enExample)
EP (2) EP2542268B1 (enExample)
JP (1) JP5770752B2 (enExample)
KR (1) KR101763700B1 (enExample)
CN (1) CN102811747B (enExample)
AU (1) AU2011222496B2 (enExample)
BR (1) BR112012022373B1 (enExample)
CA (1) CA2790143C (enExample)
CY (1) CY1123967T1 (enExample)
DK (2) DK3011975T3 (enExample)
ES (2) ES2602157T3 (enExample)
FR (1) FR21C1009I1 (enExample)
HR (2) HRP20161366T1 (enExample)
HU (3) HUE053977T2 (enExample)
IL (1) IL221541A (enExample)
IT (1) IT1398643B1 (enExample)
LT (2) LT2542268T (enExample)
MX (1) MX342323B (enExample)
NZ (1) NZ602130A (enExample)
PL (2) PL2542268T3 (enExample)
PT (2) PT3011975T (enExample)
RS (2) RS55414B1 (enExample)
RU (1) RU2561034C2 (enExample)
SI (1) SI3011975T1 (enExample)
WO (1) WO2011107945A1 (enExample)
ZA (1) ZA201206360B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
US9072583B2 (en) 2008-10-16 2015-07-07 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis
JP6671290B2 (ja) * 2014-01-29 2020-03-25 コスモ・テクノロジーズ・リミテツド 少なくとも一の染料を含むエマルションまたはマイクロエマルション形態の直腸投与用液体組成物、及びｓ状結腸及び／又は直腸の内視鏡診断方法における使用。
US10124074B2 (en) * 2014-02-26 2018-11-13 Toufic Kachaamy Indirect chromoendoscopy with an oral indigo carmine base preparation
CN118452207A (zh) 2014-12-08 2024-08-09 金诺斯公司 用于颜料消毒的添加剂组合物及其方法
EP3285701B1 (en) * 2015-04-23 2020-12-23 Obalon Therapeutics, Inc. Systems and methods for determining failure of intragastric devices
US10344251B2 (en) * 2016-02-12 2019-07-09 Kinnos, Inc. Compositions and methods for use in surface decontamination
US20190105278A1 (en) 2016-04-19 2019-04-11 Conaris Research Institute Ag Shellac microcapsule formulations and compositions
CN114874862B (zh) 2016-07-25 2025-05-30 金诺斯公司 用于表面净化的装置和相关组合物及方法
WO2018096161A1 (en) 2016-11-28 2018-05-31 Cosmo Technologies Ltd. Solid oral composition containing dyes
FR3059664B1 (fr) 2016-12-01 2019-01-25 Provepharm Life Solutions Procede de preparation du carmin d’indigo
CA3104884A1 (en) 2018-07-12 2020-01-16 Kinnos Inc. Devices, compositions, and methods for use in surface decontamination
CN108888765B (zh) * 2018-07-16 2021-02-26 山东理工大学 一种释放亚甲基蓝聚集体的含亚甲基蓝的二氧化硅/虫胶复合颗粒的制备方法
CN111184876B (zh) * 2020-02-20 2022-03-04 沈伟 一种消化道黏膜染色剂、制备方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
JP3549880B2 (ja) * 1991-10-31 2004-08-04 ジラ・インコーポレーテッド 生物学的染料組成物、調製方法および上皮癌描写への使用方法
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US6584630B1 (en) 2000-04-06 2003-07-01 Ohio Medical Instrument Company, Inc. Radiolucent surgical table extension assembly and method
WO2001076478A1 (en) 2000-04-10 2001-10-18 Nordisk Terapi As System for testing and exercising sensorimotoric control of the neck
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
US7217410B2 (en) 2003-06-17 2007-05-15 The Board Of Trustees Of The Universtiy Of Illinois Surface modified protein microparticles
US20070077202A1 (en) * 2005-06-12 2007-04-05 Pentax Corporation Histostain composition for endoscope
US20070116757A1 (en) * 2005-11-08 2007-05-24 Collegium Pharmaceutical, Inc. Methylene Blue Derivatives

Also Published As

Publication number Publication date
RU2561034C2 (ru) 2015-08-20
CY1123967T1 (el) 2022-05-27
BR112012022373B1 (pt) 2021-12-14
EP3011975A1 (en) 2016-04-27
EP2542268B1 (en) 2016-08-10
US9402923B2 (en) 2016-08-02
IT1398643B1 (it) 2013-03-08
US20160184460A1 (en) 2016-06-30
NZ602130A (en) 2014-07-25
CN102811747B (zh) 2016-02-24
EP2542268A1 (en) 2013-01-09
RU2012142192A (ru) 2014-04-10
ITMI20100345A1 (it) 2011-09-05
AU2011222496A2 (en) 2012-09-20
IL221541A (en) 2016-03-31
CA2790143C (en) 2019-01-22
LT3011975T (lt) 2021-04-26
HRP20210493T1 (hr) 2021-05-14
US9402922B2 (en) 2016-08-02
US8545811B2 (en) 2013-10-01
ES2602157T3 (es) 2017-02-17
PL3011975T3 (pl) 2021-06-28
PL2542268T3 (pl) 2017-05-31
AU2011222496A1 (en) 2012-09-20
HUS2100005I1 (hu) 2021-03-29
BR112012022373A2 (pt) 2019-11-26
US20200268909A1 (en) 2020-08-27
US20130287690A1 (en) 2013-10-31
US20130058867A1 (en) 2013-03-07
DK2542268T3 (en) 2016-11-28
CA2790143A1 (en) 2011-09-09
US10265420B2 (en) 2019-04-23
PT3011975T (pt) 2021-03-19
KR20130015008A (ko) 2013-02-12
ES2863986T3 (es) 2021-10-13
MX2012010125A (es) 2013-02-26
LT2542268T (lt) 2016-12-12
HUE053977T2 (hu) 2021-07-28
JP5770752B2 (ja) 2015-08-26
HRP20161366T1 (hr) 2017-02-24
JP2013521271A (ja) 2013-06-10
US20130295013A1 (en) 2013-11-07
ZA201206360B (en) 2013-10-30
WO2011107945A1 (en) 2011-09-09
US20180214580A1 (en) 2018-08-02
EP3011975B1 (en) 2021-01-20
AU2011222496B2 (en) 2016-08-18
SI3011975T1 (sl) 2021-05-31
RS61641B1 (sr) 2021-04-29
CN102811747A (zh) 2012-12-05
HUE030246T2 (en) 2017-04-28
DK3011975T3 (da) 2021-03-29
MX342323B (es) 2016-09-23
KR101763700B1 (ko) 2017-08-01
RS55414B1 (sr) 2017-04-28
PT2542268T (pt) 2016-11-14

Similar Documents

Publication Publication Date Title
FR21C1009I1 (fr) Composition solide pour administration orale de colorants et ses applications en diagnostic
EP2643045A4 (en) THERAPEUTIC PROCESSES AND COMPOSITIONS FOR SOLID FORM DELIVERY
EP2569626A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSING SUFFERING
PL2593090T3 (pl) Kompozycje farmaceutyczne modulatora c-Met
EP2321640A4 (en) FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS
LT3222272T (lt) Farmacinė karbetocino kompozicija
EP2748605A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2536283A4 (en) PHENYLHETEROARYL DERIVATIVES AND USE METHOD THEREFOR
EP2616076A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2558503A4 (en) COMPOSITIONS AND METHOD FOR RELEASING PAIN-STEEPING PEPTIDES IN THE BRAIN
EP2550954A4 (en) VASELINOUS COMPOSITION AND COSMETIC PREPARATION THEREOF
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
FR2964871B1 (fr) Composition cosmetique solide de maquillage
EP2525779A4 (en) LIQUID FORMULATIONS FOR A ERYTHROPOIETIN CONJUGATE WITH LONG-TERM EFFECT
EP2537907A4 (en) Release agent composition
EP2893343A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS OF INFLAMMABLE LIVER DISEASES
EP2550961A4 (en) SOLID PREPARATION
EP2536285A4 (en) SUBSTITUTED CONDENSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOUNDS AND USER METHOD THEREFOR
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
EP2625282A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM
EP2675911A4 (en) COMPOSITIONS AND METHODS OF DETERMINING HE4A
EP2394648A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
EP2540318A4 (en) SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION
EP2550960A4 (en) SOLID PREPARATION